Karan Singh Saini - Concepedia

Author

Karan Singh Saini

Central Drug Research Institute

Also Known As

K. S. Saini, Karan S Saini, Karan S. Saini, Karan Singh Saini

Publications

375

Citations

H-Index

Concepts

All Affiliations

Central Drug Research Institute Academy of Scientific and Innovative Research King George's Medical University

About

Karan Singh Saini is an author at Central Drug Research Institute specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	315
2	Cell Biology	3	3	65
3	Natural Sciences	1	1	15
4	Public Health	1	1	56
5	Biomolecular Engineering	1	1	59

Karan Singh Saini

Publications

369

Citations

H-Index

Page 1

	Year	Citations
Design and synthesis of new bioisosteres of spirooxindoles (MI-63/219) as anti-breast cancer agents Atul Kumar, Garima Gupta, Ajay Kumar Bishnoi, Bioorganic & Medicinal Chemistry Medicinal ChemistryMedicineSynthetic ChemistryPharmacologyAnti-breast Cancer Agents	2014	59
Polymorphic variations in IL-1β, IL-6 and IL-10 genes, their circulating serum levels and breast cancer risk in Indian women Pooja Singh, Preeti Chaudhary, Lakshma Vadithe Nayak, Cytokine Il-10 GenesCancer RiskCancer EpidemiologyMedicinePolymorphic Variations	2012	56
Quercetin-6-C-β-d-glucopyranoside, natural analog of quercetin exhibits anti-prostate cancer activity by inhibiting Akt-mTOR pathway via aryl hydrocarbon receptor Hamidullah, Rajeev Kumar, Karan Singh Saini, Biochimie Natural AnalogAkt-mtor PathwayMedicineAryl Hydrocarbon ReceptorPharmacotherapy	2015	46
Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines Dhanaraju Mandalapu, Karan Singh Saini, Sonal Gupta, Bioorganic & Medicinal Chemistry Letters Curcumin MimicsMedicinal ChemistryNovel Triazole HybridsSelective Anticancer ActivityChemoprevention Strategy	2016	44
<i>Saraca indica</i>Bark Extract Shows<i>In Vitro</i>Antioxidant, Antibreast Cancer Activity and Does Not Exhibit Toxicological Effects Navneet Kumar Yadav, Karan Singh Saini, Zakir Hossain, Oxidative Medicine and Cellular Longevity Chemoprevention StrategyPathologyPolyphenolicsOxidative StressMedicinal Chemistry	2015	29
Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells Kanchan Vishnoi, Rong Ke, Karan Singh Saini, Molecular Pharmacology	2020	28
Strong Impact of TGF-β1 Gene Polymorphisms on Breast Cancer Risk in Indian Women: A Case-Control and Population-Based Study Pooja Singh, Amirtharaj Francis, Singh Rajender, PLoS ONE	2013	26
Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways Ruchi Saxena, Vishal Chandra, Murli Manohar, PLoS ONE Benzopyran CompoundBreast OncologyChemotherapeutic PotentialEgfr ActivationBenzopyran Compound Cdri-85/287	2013	25
Triazole analog 1-(1-benzyl-5-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)-2-(4-bromophenylamino)-1-(4-chlorophenyl)ethanol induces reactive oxygen species and autophagy-dependent apoptosis in both in vitro and in vivo breast cancer models Hamidullah, Karan Singh Saini, Arya Ajay, The International Journal of Biochemistry & Cell Biology Cell AutophagyMedicinal ChemistryMedicineApoptosisAutophagy	2015	25
Novel alkylphospholipid-DTC hybrids as promising agents against endocrine related cancers acting via modulation of Akt-pathway Santosh Jangir, Veenu Bala, Nand Lal, European Journal of Medicinal Chemistry Medicinal ChemistryPromising AgentsEndocrine OncologyMedicineAnti-cancer Agent	2014	16

Page 1